Merck, Moderna Melanoma Vaccine Study Succeeds
Merck and Moderna announced positive results from a large late-stage trial of their personalized mRNA cancer vaccine, which significantly reduced …
معلومات السوق الآنية عبر فئات الأصول
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
Over the last 30 days, AI sentiment for MRNA skewed neutral (3 of 5 scored calls).
أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر MRNA والمشاعر والاتجاه
Merck and Moderna announced positive results from a large late-stage trial of their personalized mRNA cancer vaccine, which significantly reduced …
The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.
On this episode of Stock Movers: - RocketLab (RKLB) shares are higher this morning after rising Friday, following earnings from …
Moderna’s mRNA-based flu vaccine, mFlusiva, is approved by the Food and Drug Administration for adults aged 50 and over.
President Donald Trump discussed efforts to de-escalate US-Iran tensions with Qatari Emir Tamim bin Hamad Al Thani.
Moderna, Inc. (NASDAQ:MRNA) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage …
تحليل متعدد المزودين بالذكاء الاصطناعي